Use access key #2 to skip to page content.
$24.62 -0.89 (-3.49%)
7/3/2008 1:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating:
**

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

View All Commentary (AMLN)

Recs

1

Avatar donklenzman (86.50) Submitted: 9/14/06 10:25 AM : Outperform Start Price: $46.08 AMLN Score: -42.29

20+million diabetics

Report this Post Replies: 0 | Reply

Featured Broker Partners